No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin

byJinny TsangandAlisha Yi

July 2, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in CID.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Vancomycin and cefazolin not superior to cefazolin alone in arthroplasty prophylaxis

#VisualAbstract: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty

Oral microbiome therapy reduced Clostridioides difficile recurrence

Amivantamab and Lazertinib in Untreated EGFR-Mutated Advanced NSCLC

RelatedReports

Infectious Disease

Vancomycin and cefazolin not superior to cefazolin alone in arthroplasty prophylaxis

November 24, 2023

StudyGraphics

#VisualAbstract: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty

October 26, 2023

[Physician Comment] The extent of C. difficile infections may not differ in light of immune status

Gastroenterology

Oral microbiome therapy reduced Clostridioides difficile recurrence

January 24, 2022

StudyGraphics

#VisualAbstract: Prevalence of toxigenic and non-toxigenic asymptomatic Clostridioides difficile colonization in pediatric populations

August 11, 2021

#VisualAbstract: Adjuvant Dabrafenib plus Trametinib Improves Outcomes in Stage III Melanoma

$Bisphosphonate use and risk of atypical femur fractures$

Comparison of hip fracture risk assessment tools for elderly patients

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Merck's Capvaxive Seeks to Become the Primary Shot for Pneumococcal Disease Prevention

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result